🌍 Connect with Osivax in London! Our CEO, Alexandre Le Vert, and COO/CBDO, Delphine Guyon-Gellin, DVM, will be in London on November 19, 2024, around the Jefferies Healthcare Conference. If you’re interested in discussing Osivax’ latest innovations and partnership opportunities, don’t hesitate to reach out at contact@osivax.com. We look forward to engaging discussions in healthcare innovation! #JefferiesHealthcare #2024conference #Biotech #Innovation
Osivax’s Post
More Relevant Posts
-
Jason Spark, Chief Biotech Officer at Inizio Evoke Comms, reflects on the 2025 biotech landscape following an exciting week at this year’s annual J.P. Morgan Healthcare Conference. From the resilience of the industry to the rise of GLP-1 therapies, Jason highlights the trends, challenges, and opportunities shaping the future. Check out Jason's insights here: https://bit.ly/4htvjyt #Biotech #JPM25 #Innovation #BiotechComms #InizioEvokeComms
-
-
See Trajan in the latest Stockhead Health and Biotech Investor Guide.
In this special investor guide, #health and #biotech guru tim boreham leads Stockhead’s deep dive into the most cutting edge sector on the #ASX. Nadine McGrath Scott Power
-
Can you imagine trusting AI to treat your back pain? How about trusting AI for your therapy sessions? #biotech #AI #healthtech #Innovation
In the middle of the #BioEurope2024 crowd, we found Professor Carl Borrebaeck, Chairman of the Board at Paindrainer AB and a pioneer in precision medicine with longstanding experience in biotech innovation. In our talk, Borrebaeck shared PainDrainer's advancements in AI-driven solutions tailored to meet individual patient's needs. #HealthTech #Innovation #AIinHealthcare #ChronicPain
-
Two of the key takeaways from the recent 43rd JP Morgan Healthcare Conference for 3Biotech’s CEO, Olivier Favre-Bulle were around ‘Optimism and Adaptability’. The recent conference in San Francisco unveiled some significant announcements, innovative breakthroughs and also shone a light on areas where unmet medical needs require more focus. You can learn more about the highlights and takeaways of the conference by clicking on the link below, where Olivier has shared his thoughts about looking ahead at the biotech industry for 2025. 👇 👉 Have a look and let us know what your thoughts are too. https://lnkd.in/e8qy82ST #biotech #drugdvelopment #innovation #healthcare
-
-
Hugh upside from an investor prospective. The symbol is close to the X (formerly twitter platform), in both use of the X and stands to blur AditXt brand identity both emotionally and visually. Yes black and white can potential evoke trust but from a risk management point of view it can also evoke mistrust. As a new retail investor that believes in the platform and agenda. Consider softening the colors potentially with a blue. Again, brand recognition will immediately carry anyone to the Twitter platform and be an immediate distraction. Color Psychology- Given the sensitive nature of women's health and the importance of emotional connection with your audience, using warmer, softer colors will evoke trust, calm, empathy and most importantly approachability. Color suggestions: Soft Blue (#34B9CD3), Teal (#48C2C1), Light Green (#ABE6CF) Font suggestions: X symbol - soften with a rounded edges and consider using Serif fonts) the small lines at the extending from the bottom, this signals stability and trustworthiness. DWS2
Join us on October 28, 2024, at 11:30 AM ET for a Virtual Fireside Chat with aditXt (Nasdaq: ADTX) CEO, Amro Albanna, and Evofem Biosciences CEO, Saundra Pelletier, moderated by MD & TV Personality Dr. Drew Pinsky. The session will cover key updates on aditXt’s acquisition of Evofem, plan post-acquisition, and a live Q&A. We encourage you to engage with our panel by submitting your questions via text or video to engagement@aditxt.com by October 25, 2024, at 5:00 PM ET. Register for the event here: https://lnkd.in/g8RfryVa Read more about the event: https://lnkd.in/g4Gh2kUv #WomensHealth #Innovation #Biotech #Healthcare #Endometriosis #Womensreproductivehealth #WomensReproductiveHealth #ReproductiveAutonomy
-
-
Our business model takes a page from the #Biotech playbook by leveraging risk-reward sharing partnerships to bring clinically impactful treatments to patients. Check out CEO David Hochman's #LSIUSA24 presentation, which summarizes our unique approach to #MedTech innovation: https://bit.ly/4dphr6Y LSI #Hypertension #AtheroscleroticArteryDisease
-
-
🌟 Elevating Patient Voices in Biotech 🌟 We're diving deep into the transformative power of patient-centricity in biotechnology. Our latest blog explores how this essential approach is reshaping the development and delivery of treatments, leading to more effective and personalized healthcare solutions. Dive into the details and discover how we embrace these changes to innovate and improve patient outcomes. #Biotech #PatientCentricity #HealthcareInnovation https://lnkd.in/gTR7dwjN
-
-
Are you attending this year's #BayOConnect event? Don't miss the chance to meet our experts Wafa and Angela, and discuss how we can support you in overcoming regulatory challenges and achieving your goals. #BayOConnect #biotech #regulatoryaffairs #pharmaregulatory #healthcare #medicine
We're pleased to announce that Wafa Bouaziz, Managing Director & Head of Regulatory Affairs at Orphix Consulting GmbH, will be accompanied by Angela Bonich, Head of Business Development at DLRC Ltd, at the upcoming #BayOConnect event! BayOConnect will be held by BioM Biotech Cluster Development GmbH in Munich, where DLRC’s EU office, Orphix Consulting GmbH, has been a leading provider of specialised regulatory services since 2002. #BayOConnect serves as a premier platform, uniting visionary thinkers, innovative companies, and life science enthusiasts from Bavaria's vibrant #biotech landscape and beyond to drive advancements in #healthcare and #medicine. Are you attending this year's event? Don't miss the chance to connect with Wafa and Angela, and discuss how we can support you in overcoming regulatory challenges and achieving your goals. Email us at hello@dlrcgroup.com to schedule a meeting, or search for ‘Orphix’ in the partnering app. #LifeSciences #RegulatoryAffairs #Biotechnology #BavarianBiotech #PharmaEvents
-
"Cheers to 2025: Pioneering Innovation, Advancing Research! At Vivotech Research Lab Pvt. Ltd., we are committed to redefining clinical research with smart solutions and unparalleled expertise. Together, let’s make breakthroughs that shape the future of healthcare. Here's to a year of growth, innovation, and collaboration! #HappyNewYear2025 #VivotechResearchLab #InnovationInHealthcare #ClinicalResearchSolutions #BioEquivalence #GlobalHealthcare #InnovateWithUs #ClinicalTrialsExcellence #AdvancingScience #ResearchForward #2025Vision"
-
-
Exciting news in the world of healthcare! 🌟 These top 10 biotech companies are leading the way in revolutionizing the industry. Stay tuned to discover the game-changers shaping the future of healthcare. 💡 #biotech #healthcareinnovation
-
